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As the first line of defence against pathogens, cells mount an innate immune response, 
which varies widely from cell to cell. The response must be potent but carefully 
controlled to avoid self-damage. How these constraints have shaped the evolution of 
innate immunity remains poorly understood. Here we characterize the innate immune 
response’s transcriptional divergence between species and variability in expression 
among cells. Using bulk and single-cell transcriptomics in fibroblasts and mononuclear 
phagocytes from different species, challenged with immune stimuli, we identify the 
architecture of the innate immune response. Transcriptionally diverging genes, 
including cytokines and chemokines, vary across cells and have distinct promoter 
structures. Conversely, genes that are involved in regulation of this response, such as 
transcription factors and kinases, are conserved between species and display low cell-to-
cell variability in expression. We suggest that this expression pattern, which is observed 
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across species and conditions, has evolved as a mechanism for fine-tuned regulation to 
achieve an effective but balanced response. 
The innate immune response is a cell-intrinsic defence program that is rapidly upregulated 
upon infection in most cell types. It acts to inhibit pathogen replication while signalling the 
pathogen’s presence to other cells. This programme involves the modulation of several 
cellular pathways, including production of antiviral and inflammatory cytokines, upregulation 
of genes that restrict pathogens, and induction of cell death1,2. 
An important characteristic of the innate immune response is the rapid evolution that 
many of its genes have undergone along the vertebrate lineage3,4. This rapid evolution is 
often attributed to pathogen-driven selection5–7. 
Another hallmark of this response is its high level of heterogeneity among responding 
cells: there is extensive cell-to-cell variability in response to pathogen infection8,9 or to 
pathogen-associated molecular patterns (PAMPs)10,11. The functional importance of this 
variability is unclear. 
These two characteristics—rapid divergence in the course of evolution and high cell-
to-cell variability—seem to be at odds with the strong regulatory constraint imposed on the 
host immune response: the need to execute a well-coordinated and carefully balanced 
programme to avoid tissue damage and pathological immune conditions12–15. How this tight 
regulation is maintained despite rapid evolutionary divergence and high cell-to-cell 
variability remains unclear, but it is central to our understanding of the innate immune 
response and its evolution. 
Here, we study the evolution of this programme using two cells types—fibroblasts 
and mononuclear phagocytes—in different mammalian clades challenged with several 
immune stimuli (Fig. 1a). 
Our main experimental system uses primary dermal fibroblasts, which are commonly 
used in immunological studies8,13. We compare the response of fibroblasts from primates 
(human and macaque) and rodents (mouse and rat) to poly I:C, a synthetic double-stranded 
RNA (dsRNA; Fig. 1a, left). Poly I:C is frequently used to mimic viral infection as it rapidly 
elicits an antiviral response16. 
We comprehensively characterize the transcriptional changes between species and 
among individual cells in their innate immune response. We use population (bulk) 
transcriptomics to investigate transcriptional divergence between species, and single-cell 
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transcriptomics to estimate cell-to-cell variability in gene expression. Using promoter 
sequence analyses along with ChIP-seq, we study how changes in the expression of each 
gene between species and across cells relate to the architecture of its promoter. Furthermore, 
we examine the relationship between cross-species divergence in gene sequence and 
expression and constraints imposed by host-pathogen interactions. 
Additionally, we use a second system—bone marrow-derived mononuclear 
phagocytes from mouse, rat, rabbit and pig challenged with lipopolysaccharide (LPS), a 
commonly used PAMP of bacterial origin (Fig. 1a, right). 
Taken together, these two systems provide insights into the architecture of the 
immune response across species, cell types and immune challenges. 
Transcriptional divergence in immune response 
First, we studied the transcriptional response of fibroblasts to stimulation with dsRNA (poly 
I:C) across the four species (human, macaque, rat and mouse). We generated bulk RNA-
sequencing (RNA-seq) data for each species after 4 h of stimulation, along with respective 
controls (see Fig. 1a and Methods). 
In all species, dsRNA treatment induced rapid upregulation of genes encoding 
expected antiviral and inflammatory products, including IFNB, TNF, IL1A and CCL5 (see 
also Supplementary Table 3). Focusing on one-to-one orthologues, we performed correlation 
analysis between species and observed a similar transcriptional response (Spearman 
correlation, P < 10−10 in all comparisons; Extended Data Fig. 1), as reported in other immune 
contexts17–19. Furthermore, the response tended to be more strongly correlated between 
closely related species than between more distantly related species, as in other expression 
programmes20–24. 
We characterized the differences in response to dsRNA between species for each 
gene, using these cross-species bulk transcriptomics data. While some genes, such as those 
encoding the NF-B subunits RELB and NFKB2, respond similarly across species, other 
genes respond differently in the primate and rodent clades (Fig. 1b, left). For example, IFI27 
(a restriction factor against numerous viruses) is strongly upregulated in primates but not in 
rodents, whereas DAXX (an antiviral transcriptional repressor) exhibits the opposite 
behaviour. 
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Similarly, in our second experimental system, which consists of lipopolysaccharide 
(LPS)-stimulated mononuclear phagocytes from mouse, rat, rabbit, and pig (Fig. 1b, right), 
some genes responded similarly across species (for example, Nfkb2), whereas others were 
highly upregulated only in specific clades (for example, Phlda1). 
To quantify transcriptional divergence in immune responses between species, we 
focused on genes that were differentially expressed during the stimulation (see Methods). For 
simplicity, we refer to these genes as ‘responsive genes’ (Fig. 1c). In this analysis, we study 
the subset of these genes with one-to-one orthologues across the studied species. There are 
955 such responsive genes in dsRNA-stimulated human fibroblasts and 2,336 in LPS-
stimulated mouse phagocytes. We define a measure of response divergence by calculating the 
differences between the fold-change estimates while taking the phylogenetic relationship into 
account (Methods, Supplementary Figs. 1–7 and Supplementary Table 4).  
For subsequent analyses, we split the 955 genes that were responsive in fibroblasts 
into three groups on the basis of their level of response divergence: (1) high-divergence 
dsRNA-responsive genes (the top 25% of genes with the highest divergence values in 
response to dsRNA across the four studied species); (2) low-divergence dsRNA-responsive 
genes (the bottom 25%); and (3) genes with medium divergence across species (the middle 
50%; Fig. 1c). We performed an analogous procedure for the 2,336 LPS-responsive genes in 
phagocytes. [Author: In normal English usage, ‘lowly’ is not the opposite of ‘highly’; 
therefore I have changed ‘highly divergent genes’ and ‘lowly divergent genes’ to ‘high-
divergence genes’ and ‘low-divergence genes’, respectively; ok?] 
Promoter architecture of diverging genes 
Next, we tested whether divergence in transcriptional responses is reflected in the 
conservation of promoter function and sequence. Using chromatin immunoprecipitation with 
sequencing (ChIP–seq), we profiled active histone marks in the fibroblasts of all species. The 
presence of trimethylation of lysine 4 on histone H3 (H3K4me3) in promoter regions of high-
divergence genes was significantly [Author: We reserve ‘significantly’ to refer to 
statistical significance. If you are referring here to statistical significance, please give P 
value; otherwise, please replace with ‘substantially’ or similar; also where highlighted 
below.] less conserved between humans and rodents than was the presence of H3K4me3 in 
promoters of low-divergence genes (Extended Data Fig. 2). 
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology article 
 DOI: 2017-08-11208C 
Page 6 of 40 
We then used the human H3K4me3 ChIP–seq peaks to define active promoter regions 
of the responsive genes in human fibroblasts. The density of transcription factor binding 
motifs (TFBMs) was significantly higher in the active promoter regions of high-divergence 
genes than in low-divergence genes (Fig. 2a). Notably, when comparing the conservation of 
the core promoter regions in high- versus low-divergence dsRNA-responsive genes, we 
found that genes that diverge highly in response to dsRNA show higher sequence 
conservation in this region (Fig. 2b). 
This unexpected discordance may be related to the fact that promoters of high- and 
low-divergence genes have distinctive architectures, associated with different constraints on 
promoter sequence evolution18,25,26. Notably, promoters containing TATA-box elements tend 
to have most of their regulatory elements in regions immediately upstream of the 
transcription start site (TSS). These promoters are thus expected to be more conserved. The 
opposite is true for CpG island (CGI)26,27 promoters. Indeed, we found that TATA-boxes are 
associated with higher transcriptional divergence, while genes with CGIs diverge more 
slowly, both in fibroblasts and phagocytes (Fig. 2c; Extended Data Fig. 3). Thus, a promoter 
architecture enriched in TATA-boxes and depleted of CGIs is associated with higher 
transcriptional divergence, while entailing higher sequence conservation upstream of these 
genes18,26,27. 
Cytokines diverge rapidly in immune response 
We next investigated whether different functional classes among responsive genes are 
characterized by varying levels of transcriptional divergence. To this end, we divided 
responsive genes into categories according to function (such as cytokines, transcriptional 
factors and kinases) or the processes in which they are known to be involved (such as 
apoptosis or inflammation). 
Genes related to cellular defence and inflammation—most notably cytokines, 
chemokines and their receptors (hereafter ‘cytokines’)—tended to diverge in response 
significantly faster than genes involved in apoptosis or immune regulation (chromatin 
modulators, transcription factors, kinases and ligases) (Fig. 2d, e, Extended Data Fig. 4, 
Supplementary Fig. 1). 
Cytokines also had a higher transcriptional range in response to immune challenge (a 
higher fold-change). Regressing the fold-change from the divergence estimates resulted in 
reduction of the relative divergence of cytokines versus other responsive genes, but the 
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difference still remained significant (Supplementary Fig. 2). Cytokine promoters are enriched 
in TATA-boxes (17% versus 2.5%, P = 1.1 × 10−3, Fisher’s exact test) and depleted of CGIs 
(14% versus 69%, P = 1.6 × 10−9), suggesting that this promoter architecture is associated 
both with greater differences between species (response divergence) and larger changes 
between conditions (transcriptional range). 
Cell-to-cell variability in immune response 
Previous studies have shown that the innate immune response displays high variability across 
responding cells28,29. However, the relationship between cell-to-cell transcriptional variability 
and response divergence between species is not well understood. 
To study heterogeneity in gene expression across individual cells, we performed 
single-cell RNA-seq in all species in a time course following immune stimulation. We 
estimated cell-to-cell variability quantitatively using an established measure for variability: 
distance to median (DM)30. 
We found a clear trend in which genes that were highly divergent in response between 
species were also more variable in expression across individual cells within a species (Fig. 
3a). The relationship between rapid divergence and high cell-to-cell variability held true in 
both the 955 dsRNA-responsive genes in fibroblasts and the 2,336 LPS-responsive genes in 
phagocytes. This can be observed across the stimulation time points and in different species 
(Extended Data Figs. 5, 6). We analysed in depth the relationship between transcriptional 
divergence and cell-to-cell variability by using additional immune stimulation protocols 
(Supplementary Figs. 8, 9), and different experimental and computational approaches 
(Extended Data Fig. 7, Supplementary Figs. 10–13). Notably, the trends we observed are not 
a result of technical biases due to low expression levels in either the bulk or the single-cell 
RNA-seq data (Supplementary Figs. 14, 15). 
Next, we examined the relationship between the presence of promoter elements (CGIs 
and TATA-boxes) and a gene’s cell-to-cell variability. Genes that are predicted to have a 
TATA-box in their promoter had significantly higher transcriptional variability, whereas 
CGI-containing genes tended to have lower variability (Fig. 3b), in agreement with previous 
findings31. Thus, both transcriptional variability between cells (Fig. 3b) and transcriptional 
divergence between species (Fig. 2c) are associated with the presence of specific promoter 
elements. 
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Transcriptional variability of cytokines 
We subsequently compared the response divergence across species with the transcriptional 
cell-to-cell variability of three groups of responsive genes with different functions: cytokines, 
transcription factors, and kinases and phosphatases (hereafter ‘kinases’; Fig. 3c, Extended 
Data Fig. 8). In contrast to kinases and transcription factors, many cytokines display 
relatively high levels of cell-to-cell variability (Extended Data Fig. 9), being expressed only 
in a small subset of responding cells (Extended Data Fig. 10). This has previously been 
reported for several cytokines29. For example, IFNB is expressed in only a small fraction of 
cells infected with viruses or challenged with various stimuli8,11,32. Here, we find that cells 
show high levels of variability in expression of cytokines from several families (for example, 
IFNB, CXCL10 and CCL2). 
Cell-to-cell variability of cytokines remains relatively high in comparison to kinases 
and transcription factors during a time course of 2, 4 and 8 h after dsRNA stimulation of 
fibroblasts (Extended Data Fig. 9). This pattern is similar across species, and can also be 
observed in LPS-stimulated phagocytes (Extended Data Fig. 9). Thus, the high variability of 
cytokines and their expression in a small fraction of stimulated cells across all time points is 
evolutionarily conserved. 
Ccytokines tended to be co-expressed in the same cells, raising the possibility that 
their expression is coordinated (see Supplementary Information and Supplementary Fig. 16). 
We also identified genes whose expression was correlated with cytokines in human 
fibroblasts and showed that their orthologues are significantly co-expressed with cytokines in 
other species. This set is enriched with genes known to be involved in cytokine regulation 
(Supplementary Table 5). 
As an example, we focused on the genes whose expression is positively correlated 
with the chemokine CXCL10 in at least two species (Fig. 3d). This set includes four 
cytokines co-expressed with CXCL10 (in purple), as well as known positive regulators of the 
innate immune response and cytokine production (in blue), such as the viral sensors IFIH1 
(also known as MDA5) [Author: Changed to HUGO symbol per our style, ok? Changed 
in Fig. 3 also.] and RIG-I [Author: I could not find RIG-1 in the HUGO database. Do 
you mean mouse Rig1 (regulation of Igh-1b 1) or DDX58 (DExD/H-box helicase 58, 
synonym RIG-1?]. This is in agreement with previous evidence that IFNB expression is 
limited to cells in which important upstream regulators are expressed at sufficiently high 
levels8,11,32. We show that this phenomenon of co-expression with upstream regulators 
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applies to a wide set of cytokines and is conserved across species. Notably, cytokines were 
co-expressed not only with their positive regulators but also with genes that are known to act 
as negative regulators of cytokine expression or cytokine signalling (in red), suggesting that 
cytokine expression and function is tightly controlled at the level of individual cells. 
The evolutionary landscape of innate immunity 
Many immune genes, including several cytokines and their receptors, have been shown to 
evolve rapidly in coding sequence3,33. However, it is not known how divergence in coding 
sequence relates to transcriptional divergence in innate immune genes. Using the set of 955 
dsRNA-responsive genes in fibroblasts, we assessed coding sequence evolution in the three 
subsets of low-, medium- and high-divergence genes (as defined in Fig. 1c). 
We compared the rate at which genes evolved in their coding sequences with their 
response divergence by considering the ratio of non-synonymous (dN) to synonymous 
substitutions (dS). Genes that evolved rapidly in transcriptional response had higher coding 
sequence divergence (higher dN/dS values) than dsRNA-responsive genes with low response 
divergence (Fig. 4a). 
Rapid gene duplication and gene loss have been observed in several important 
immune genes34–39 and are thought to be a result of pathogen-driven pressure40,41. We 
therefore tested the relationship between a gene’s divergence in response and the rate at 
which the gene’s family has expanded and contracted in the course of vertebrate evolution. 
We found that transcriptionally divergent dsRNA-responsive genes have higher rates of gene 
gain and loss (Fig. 4b) and consequently are also evolutionarily younger (Fig. 4c, 
Supplementary Fig. 17). 
Previous reports have suggested that proteins encoded by younger genes tend to have 
fewer protein–protein interactions (PPIs) within cells42. Indeed, we found that rapidly 
diverging genes tend to have fewer PPIs (Fig. 4d). Together, these results suggest that 
transcriptionally divergent dsRNA-responsive genes evolve rapidly through various 
mechanisms, including fast coding sequence evolution and higher rates of gene loss and 
duplication events, and that their products have fewer interactions with other cellular proteins 
than those of less divergent genes [Author: Correct as edited?]. 
The interaction between pathogens and the host immune system is thought to be an 
important driving force in the evolution of both sides. We therefore investigated the 
relationship between transcriptional divergence and interactions with viral proteins by 
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compiling a data set of known host–virus interactions in humans6,43,44. Notably, genes whose 
products had no known viral interactions showed higher response divergence than genes 
encoding proteins with viral interactions [Author: Correct as edited?] (Fig. 4e). 
Furthermore, the transcriptional divergence of genes targeted by viral immunomodulators45—
viral proteins that subvert the host immune system—was lower still (Fig. 4e). These 
observations suggest that viruses have evolved to modulate the immune system by interacting 
with immune proteins that are relatively conserved in their response. Presumably, these genes 
cannot evolve away from viral interactions, unlike host genes that are less constrained46. 
The summary of our results in Fig. 4f highlights the differences in both regulatory and 
evolutionary characteristics between cytokines and other representative dsRNA-responsive 
genes. Cytokines evolve rapidly through various evolutionary mechanisms and have higher 
transcriptional variability across cells. By contrast, genes that are involved in immune 
response regulation, such as transcription factors and kinases, are more conserved and less 
heterogeneous across cells. These genes encode proteins that have more interactions with 
other cellular proteins, [Author: Correct as edited?] suggesting that higher constraints are 
imposed on their evolution. This group of conserved genes is more often targeted by viruses, 
revealing a relationship between host–pathogen dynamics and the evolutionary landscape of 
the innate immune response. 
Discussion 
Here, we have charted the evolutionary architecture of the innate immune response. We show 
that genes that diverge rapidly between species show higher levels of variability in their 
transcription across individual cells than genes that diverge more slowly [Author: Correct 
as edited?]. Both of these characteristics are associated with a similar promoter architecture, 
enriched in TATA-boxes and depleted of CGIs. Notably, such promoter architecture is also 
associated with the high transcriptional range of genes during the immune response. Thus, 
transcriptional changes between conditions (stimulated versus unstimulated), species 
(transcriptional divergence), and individual cells (cell–cell variability) may all be 
mechanistically related to the same promoter characteristics. In yeast, TATA-boxes are 
enriched in promoters of stress-related genes, displaying rapid transcriptional divergence 
between species and high variability in expression30,47. This finding suggests intriguing 
analogies between the mammalian immune and yeast stress responses—two systems that 
have been exposed to continuous changes in external stimuli during evolution. 
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We have also shown that genes involved in regulation of the immune response—such 
as transcription factors and kinases—are relatively conserved in their transcriptional 
responses. These genes might be under stronger functional and regulatory constraints, owing 
to their roles in multiple contexts and pathways, which would limit their ability to evolve. 
This limitation could represent an Achilles’ heel that is used by pathogens to subvert the 
immune system. Indeed, we found that viruses interact preferentially with conserved proteins 
of the innate immune response. Cytokines, on the other hand, diverge rapidly between 
species, owing to their promoter architecture and because they have fewer constraints 
imposed by intracellular interactions or additional non-immune functions. We therefore 
suggest that cytokines represent a successful host strategy to counteract rapidly evolving 
pathogens as part of the host–pathogen evolutionary arms race. 
Cytokines also display high cell–cell variability and tend to be co-expressed with 
other cytokines and cytokine regulators in a small subset of cells, and this pattern is 
conserved across species. As prolonged or increased cytokine expression can result in tissue 
damage48–50, restriction of cytokine production to only a few cells may enable a rapid, but 
controlled, response across the tissue to avoid long-lasting and potentially damaging effects. 
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[Author: Please ensure that the following information is included in the figure legends where 
relevant. Sample size (exact n number); a statement of replicability (how many times was 
experiment replicated in the laboratory); description of sample collection (clarify whether 
technical or biological replicates and include how many animals, litters, cultures, etc.); state 
the statistical test used and give P values; define centre values (median or average) and error 
bars. For figures/images that are reproduced or adapted from a third party, it is important that 
you confirm that permission has been obtained and that appropriate acknowledgement of the 
copyright holder is given.] 
Fig. 1 | Response divergence across species in innate immune response. a, Study design. 
Left, primary dermal fibroblasts from mouse, rat, human and macaque stimulated with 
dsRNA or controls. Samples were collected for bulk and single-cell RNA-seq and ChIP–seq. 
Right, primary bone marrow-derived mononuclear phagocytes from mouse, rat, rabbit and 
pig stimulated with LPS or controls. Samples were collected for bulk and single-cell RNA-
seq. b, Left, fold-change (FC) in dsRNA stimulation in fibroblasts for sample genes across 
species (edgeR exact test, based on n = 6, 5, 3, 3 individuals from human, macaque, rat and 
mouse, respectively). Right, fold-change in LPS stimulation in phagocytes for sample genes 
across species (Wald test implemented in DESeq2, based on n = 3 individuals from each 
species). FDR-corrected P values are shown (***P < 0.001, **P < 0.01, *P < 0.05). c, Top, 
estimating each gene’s level of cross-species divergence in transcriptional response to 
dsRNA stimulation in fibroblasts. Using differential expression analysis, fold-change in 
dsRNA response was assessed for each gene in each species. We identified 1,358 human 
genes as differentially expressed (FDR-corrected q < 0.01), of which 955 had one-to-one 
orthologues across the four studied species. For each gene with one-to-one orthologues across 
all species, a response divergence measure was estimated using: response 
divergence = log[1/4 × i,j(log[FC primatei] − [logFC rodentj])2]. [Author: Equations have 
been rekeyed, please check carefully.] Genes were grouped into low, medium and high 
divergence according to their response divergence values for subsequent analysis. Bottom, 
estimating each gene’s level of cross-species divergence in LPS response in mononuclear 
phagocytes. A response divergence measure was estimated using: response 
divergence = log[1/3 × j(log[FC pig] − log[FC glirej])2] (where glires are mouse, rat and 
rabbit). 
Fig. 2 | Transcriptionally divergent genes have unique functions and promoter 
architectures. a, TFBM density in active promoters and response divergence. For each gene 
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studied in fibroblast dsRNA stimulation, the total number of TFBM matches in its H3K4me3 
histone mark was divided by the length of the mark (human marks were used; n = 879 
differentially expressed genes with ChIP–seq data). High-divergence genes have higher 
TFBM density than low-divergence genes (one-sided Mann–Whitney test). b, Promoter 
sequence conservation and response divergence in fibroblast dsRNA stimulation. Sequence 
conservation values are estimated with phyloP7 for 500 base pairs upstream of the TSS of the 
human gene. Mean conservation values of each of the 500 base pairs upstream of the TSS are 
shown for high-, medium- and low-divergence genes (n = 840 genes). Genes that are highly 
divergent have higher sequence conservation (one-sided Kolmogorov–Smirnov test). The 
95% confidence interval for predictions from a linear model computed by geom_loess 
function is shown in grey. c, Comparison of divergence in response of genes with and 
without a TATA-box and CGIs in fibroblast dsRNA stimulation and phagocyte LPS 
stimulation. TATA-box matches and CGI overlaps were computed with respect to the TSS of 
human genes in fibroblasts (n = 955 genes), and to the TSS of mouse genes in phagocytes 
(n = 2,336). d, Distributions of divergence values of 9,753 expressed genes in fibroblasts, 
955 dsRNA-responsive genes and different functional subsets of the dsRNA-responsive 
genes (each subset is compared with the set of 955 genes using a one-sided Mann–Whitney 
test and FDR-corrected P values are shown). e, Distributions of divergence values of 6,619 
expressed genes in phagocytes, 2,336 LPS-responsive genes and different functional subsets 
of the LPS-responsive genes (each subset is compared with the set of 2,336 genes using a 
one-sided Mann–Whitney test and FDR-corrected P values are shown). Violin plots show the 
kernel probability density of the data. Boxplots represent the median, first quartile and third 
quartile with lines extending to the furthest value within 1.5 of the inter-quartile range (IQR). 
Fig. 3 | Cell–cell variability in immune response corresponds to response divergence. a, 
Comparison of divergence in response across species with transcriptional variability between 
individual cells. Top, fibroblast dsRNA stimulation (variability measured in n = 55 human 
cells, following 4 h dsRNA stimulation). Bottom, phagocyte LPS stimulation (variability 
measured in n = 3,293 mouse cells, following 4 h LPS stimulation). Genes classified as high-, 
medium- or low-divergence according to level of response divergence. Cell–cell variability 
values of high-divergence genes were compared with those of low-divergence genes (one-
sided Mann–Whitney test). b, Comparison of cell–cell variability of genes with and without a 
TATA-box and CGI, in fibroblast dsRNA stimulation and phagocyte LPS stimulation (one-
sided Mann–Whitney test). Cell–cell variability values are from DM estimations of human 
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fibroblasts stimulated with dsRNA for 4 h (n = 55 cells) and from mouse phagocytes 
stimulated with LPS for 4 h (n = 3,293 cells). c, Scatter plot showing divergence in response 
to dsRNA in fibroblasts across species and transcriptional cell–cell variability in human cells 
following 4 h of dsRNA stimulation (n = 684 dsRNA-responsive genes). Purple, cytokines; 
green, transcription factors; beige, kinases. The distributions of divergence and variability 
values of these groups are shown above and to the right of the scatter plot, respectively. d, A 
network showing genes that correlate positively in expression with the chemokine CXCL10 
across cells (Spearman correlation,  > 0.3), in at least two species, following dsRNA 
treatment in fibroblasts (based on n = 146, 74, 175 and 170 human, macaque, rat and mouse 
cells, respectively). Purple, cytokines; red, positive regulators of cytokine expression; blue, 
negative regulators. Colours of lines [Author: Correct as edited?], from light to dark grey, 
reflect the number of species in which this pair of genes was correlated. Boxplots represent 
the median, first quartile and third quartile with lines extending to the furthest value within 
1.5 × IQR. [Author: LGP2 changed to DHX58 (HUGO symbol) per our style, ok? Also 
FAM46A changed to TENT5A.]  
Fig. 4 | Relationship of response divergence and other evolutionary modes. a–d, dsRNA-
responsive genes in fibroblasts are divided by level of response divergence into three groups, 
as in Fig. 1c. a, Coding sequence divergence, as measured using dN/dS values across 29 
mammals. Higher dN/dS values denote faster coding sequence evolution (n = 567 genes). b, 
Rate at which genes were gained and lost within the gene family across the vertebrate clade 
(plotted as –logP). Higher values denote faster gene gain and loss rate (n = 955 genes). c, 
Evolutionary age (estimated with Panther7 phylogeny and Wagner reconstruction algorithm). 
Values denote the branch number with respect to human (distance from human in the 
phylogenetic tree); higher values indicate greater age (n = 931 genes). d, Number of known 
physical interactions with other cellular proteins (n = 955 genes). e, Distribution of 
transcriptional response divergence values among dsRNA-responsive genes whose protein 
products do not interact with viruses, interact with at least one virus, or interact with viral 
immunomodulators (n = 648, 377 and 25 genes, respectively). a–e, One-sided Mann–
Whitney tests. f, A scaled heatmap showing values of response divergence (as in Fig. 1c), 
cell–cell variability (as in Fig. 3a), coding sequence divergence (dN/dS values, as in Fig. 4a), 
gene age (as in Fig. 3c; younger genes have darker colours), number of cellular PPIs (as in 
Fig. 4d) and number of host–virus interactions (as in Fig. 4e), for example genes from three 
functional groups: cytokines, transcription factors, and kinases. Values are shown in a 
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normalized scale between 0 and 100, with the gene with the highest value assigned a score of 
100. Missing values are shown in white. Boxplots represent the median, first quartile and 
third quartile with lines extending to the furthest value within 1.5 × IQR. Violin plots show 
the kernel probability density of the data. 
[Author: Please ensure that the following information is provided in the Methods section 
where relevant. Animal experiments require: statement about randomization; statement about 
blinding; statement of sex, age, species and strain of animals; statement of IRB approval for 
live vertebrate experimentation. For experiments involving humans: statement of IRB 
approval; statement of informed consent; statement of consent to publish any photos included 
in figures. Randomized clinical trials require trial registration. We recommend that detailed 
protocols are deposited in Protocol Exchange, or a similar repository. If custom computer 
code has been used and is central to the conclusions of this paper, please insert a section into 
the Methods titled ‘Code availability’ and indicate within this section whether and how the 
code can be accessed, including any restrictions to access.] 
[Author: We assume no power analysis was done to estimate sample size; per our reporting 
guidelines we will include the statement ‘No statistical methods were used to predetermine 
sample size.’ Please edit if appropriate.] 
[Author: In order to address the issue of cell line misidentification and cross-contamination, 
for any cell lines mentioned in the paper please provide source of the cell lines and indicate 
whether the cell lines have been correctly identified/authenticated (if so, by what methods). 
Also, please state whether cell lines have been tested for mycoplasma contamination.] 
[Author: We assume there was no randomization; per our reporting guidelines, we will 
include the statement “The experiments were not randomized”. Also, we assume that there 
was no blinding; per our reporting guidelines, we will include the statement “The 
investigators were not blinded to allocation during experiments and outcome assessment”. 
Please edit either of these statements if necessary.] 
METHODS 
Ethical compliance 
This project was approved by the Wellcome Sanger Institute Animal Welfare and Ethical 
Review Body, and complied with all relevant ethical regulations regarding animal research 
and human studies. Human cells were obtained from the Hipsci project51, where they were 
collected from volunteers recruited from the NIHR Cambridge BioResource (written consent 
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology article 
 DOI: 2017-08-11208C 
Page 20 of 40 
was given). Human skin profiling was performed in accordance with protocols approved by 
the Newcastle Research Ethics Committee (REC approval 08/H0906/95+5). Macaque skin 
samples were obtained from animals assigned to unrelated non-infectious studies, provided 
by Public Health England’s National Infection Service in accordance with Home Office (UK) 
guidelines and approved by the Public Health England Ethical Review Committee under an 
appropriate UK Home Office project license. [Author: We have only two levels of 
subheading in Methods: Bold (separate line) and italic (run-on). Please check that you 
are happy with how I have formatted your headings.] 
Cross-species dermal fibroblast stimulation with dsRNA and IFNB 
Tissue culture. We cultured primary dermal fibroblasts from low passage cells (below 10) 
that originated from females from four different species (human (European ancestry), rhesus 
macaque, C57BL/6 (black 6) mouse and brown Norway rat). All skin samples were taken 
from shoulders. Stimulation experiments and library preparations were done in identical 
conditions across all species and for all genomics techniques. Details on the numbers of 
individuals used in each technique are listed in each technique’s section and in 
Supplementary Table 1. 
Human cells were obtained from the Hipsci project51 (http://www.hipsci.org/). Rhesus 
macaque cells were extracted from skin tissues that were incubated for 2 h with 0.5% 
collagenase B (Roche; 11088815001) after mechanical processing, and then filtered through 
100-µm strainers before being plated and passaged before cryo-banking. Rodent cells were 
obtained from PeloBiotech where they were extracted using a similar protocol. In vitro 
cultured fibroblasts from all four species resemble a particular in vivo cluster of dermal 
fibroblasts (see Supplementary Information). 
Prior to stimulation, cells were thawed and grown for several days in ATCC fibroblast 
growth medium (Fibroblast Basal Medium (ATCC, ATCC-PCS-201-030) with Fibroblast 
Growth Kit-Low serum (ATCC, PCS-201-041) (supplemented with Primocin (Invivogen, 
ant-pm-1) and penicillin/streptomycin (Life Technologies, Cat. Code: 15140122))—a 
controlled medium that has proven to provide good growing conditions for fibroblasts from 
all species, with slightly less than 24 h doubling times. About 18 h before stimulation, cells 
were trypsinized, counted and seeded into 6-well plates (100,000 cells per well). Cells were 
stimulated as follows: (1) stimulated with 1 g/ml high-molecular weight poly I:C 
(Invivogen, Cat. Code: tlrl-pic) transfected with 2 g/ml Lipofectamin 2,000 (ThermoFisher, 
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology article 
 DOI: 2017-08-11208C 
Page 21 of 40 
Cat Number 11668027); (2) mock transfected with Lipofectamin 2,000; (3) stimulated with 
1,000 IU of IFNB for 8 h (human IFNB: 11410-2 (for human and macaque cells); rat IFNB: 
13400-1; mouse IFNB: 12401-1; all IFNs were obtained from PBL, and had activity units 
based on similar virological assays); or (4) left untreated. Interferon stimulation was used as a 
control, to study how genes that were upregulated in the secondary wave of the innate 
immune response diverge between species. 
Additional human and mouse samples were stimulated with 1,000 IU of cross-
mammalian IFN (CMI, or Universal Type I IFN Alpha, PBL, 11200-1). The latter stimulation 
was done to assess the effects of species-specific and batch-specific IFNB. 
In all of the above-mentioned stimulations, we used a longer time course for single-
cell RNA-seq than for bulk RNA-seq, for two main reasons: (1) in the bulk, we chose to 
focus on one main stimulation time point for simplicity and to obtain an intuitive fold-change 
between stimulated and unstimulated conditions; (2) in single cells, when studying cell–cell 
variability, we chose to profile, in addition to the main stimulation time point, cells in earlier 
and later stages of the response. This is important for studying how the dynamics and 
magnitude of the response affect gene expression variability between responding cells. 
The poly I:C we used tested negative for the presence of bacterial beta-endotoxin 
using a coagulation test (PYROGENT Plus, 0.06 EU/ml sensitivity, N283-06). 
Bulk RNA sequencing: library preparation and sequencing. For bulk transcriptomics 
analysis, cells [Author: Correct as edited? Or ‘cells from individuals’] from different 
species were grown in parallel and stimulated with dsRNA, IFNB (and cross-mammalian 
IFN) and their respective controls. In total, samples from 6 humans, 6 macaques, 3 mice and 
3 rats were used. Total RNA was extracted using the RNeasy Plus Mini kit (Qiagen, 74136), 
using QIAcube (Qiagen). RNA was then measured using a Bioanalyzer 2100 (Agilent 
Technologies), and samples with RIN < 9 were excluded from further analysis (one macaque 
sample stimulated with poly I:C and its control). 
Libraries were produced using the Kapa Stranded mRNA-seq Kit (Kapa Biosystems, 
Kit code: KK8421). The Kapa library construction protocol was modified for automated 
library preparation by Bravo (Agilent Technologies). cDNA was amplified in 13 PCR cycles, 
and purified using Ampure XP beads (Beckman Coulter, A63882) (1.8× volume) using 
Zephyr (Perkin Elmer). Pooled samples were sequenced on an Illumina HiSeq 2500 
instrument, using paired-end 125-bp reads. 
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ChIP–seq: library preparation and sequencing. Samples from three individuals from each of 
the four species were grown and stimulated (with poly I:C for 4 h or left untreated, as 
described above) in parallel to samples collected for bulk RNA-seq. Following stimulation, 
samples were crosslinked in 1% HCHO (prepared in 1× DPBS) at room temperature for 10 
min, and HCHO was quenched by the addition of glycine at a final concentration of 0.125 M. 
Cells were pelleted at 4 °C at 2,000g, washed with ice-cold 1× DPBS twice, and snap-frozen 
in liquid nitrogen. Cell pellets were stored at –80 °C until further stages were performed. 
ChIPmentation was performed according to version 1.0 of the published protocol52 with a 
few modifications (see additional details in Supplementary Methods). 
Library preparation reactions contained the following reagents: 10 l purified DNA 
(from the above procedure), 2.5 l PCR Primer Cocktails (Nextera kit, Illumina, FC-121-
1030), 2.5 l N5xx (Nextera index kit, Illumina FC-121-1012), 2.5 l N7xx (Nextera index 
kit, Illumina, FC-121-1012), 7.5 l NPM PCR Master Mix (Nextera kit, Illumina, FC-121-
1030). PCR cycles were as follows: 72 °C, 5 min; 98 °C, 2 min; [98 °C, 10 s, 63 °C, 30 s, 72 
°C, 20 s] × 12; 10 °C hold. 
Amplified libraries were purified by double AmpureXP bead purification: first with 
0.5× bead ratio, keep supernatant, second with 1.4× bead ratio, keep bound DNA. Elution 
was done in 20 l Buffer EB (QIAGEN). 
One microlitre of library was run on a Bioanalyzer (Agilent Technologies) to verify 
normal size distribution. Pooled samples were sequenced on an Illumina HiSeq 2000 
instrument, using paired-end 75-bp reads. 
Single-cell RNA-seq: flow cytometry. For scRNA-seq, we performed two biological 
replicates, with each replicate having one individual from each of the four studied species. A 
time course of dsRNA stimulation of 0, 4, and 8 h was used in one replicate (divided into two 
technical replicates), while the second replicate included a time course of 0, 2, 4, and 8 h. 
Poly I:C transfection was done as described above. In the case of sorting with IFNLUX, we 
used rhodamine-labelled poly I:C. 
Cells were sorted with either Beckman Coulter MoFlo XDP (first replicate) or Becton 
Dickinson INFLUX (second replicate) into wells containing 2 l lysis buffer (1:20 solution 
of RNase Inhibitor (Clontech, 2313A) in 0.2% v/v Triton X-100 (Sigma-Aldrich, T9284)), 
spun down and immediately frozen at –80 °C. 
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When sorting with MoFlo, a pressure of 15 psi was used with a 150-µm nozzle, using 
the ‘Single’ sort purity mode. Dead or late-apoptosis cells were excluded using propidium 
iodide at 1 µg/ml (Sigma, Cat Number P4170) and single cells were selected using FSC W 
versus FSC H. When sorting with INFLUX, a pressure of 3 psi was used with a 200-µm 
nozzle, with the ‘single’ sort mode. Dead or late-apoptosis cells were excluded using 100 
ng/ml DAPI (4,6-diamidino-2-phenylindole) (Sigma, D9542). DAPI was detected using the 
355-nm laser (50 mW), using a 460/50 nm bandpass filter. Rhodamine was detected using the 
561-nm laser (50mW), using a 585/29 nm bandpass filter. Single cells were collected using 
FSC W versus FSC H. 
Library preparation from full-length RNA from single cells and sequencing. Sorted plates 
were processed according to the Smart-seq2 protocol53. Oligo-dT primer (IDT), dNTPs 
(ThermoFisher, 10319879) and ERCC RNA Spike-In Mix (1:25,000,000 final dilution, 
Ambion, 4456740) were added to each well, and reverse transcription (using 50 U 
SmartScribe, Clontech, 639538) and PCR were performed following the original protocol 
with 25 PCR cycles. cDNA libraries were prepared using Nextera XT DNA Sample 
Preparation Kit (Illumina, FC-131-1096), according to the protocol supplied by Fluidigm (PN 
100-5950 B1). Quality Checks on cDNA were done using a Bioanalyser 2100 (Agilent 
Technologies). Libraries were quantified using the LightCycler 480 (Roche), pooled and 
purified using AMPure XP beads (Beckman Coulter) with Hamilton 384 head robot 
(Hamilton Robotics). Pooled samples were sequenced on an Illumina HiSeq 2500 instrument, 
using paired-end 125-bp reads. 
Cross-species response divergence: read mapping to annotated transcriptome. For bulk 
RNA-seq samples, adaptor sequences and low-quality score bases were first trimmed using 
Trim Galore (version 0.4.1) (with the parameters ‘–paired–quality 20–length 20 -e 0.1–
adapter AGATCGGAAGAGC’). Trimmed reads were mapped and gene expression was 
quantified using Salmon (version 0.6.0)54 with the following command: ‘salmon quant -i 
[index_file_directory] -l ISR -p 8–biasCorrect–sensitive–extraSensitive -o [output_directory] 
-1 -g [ENSEMBL_transcript_to_gene_file]–useFSPD–numBootstraps 100’. Each sample was 
mapped to its respective species’ annotated transcriptome (downloaded from ENSEMBL, 
version 84: GRCh38 for human, MMUL_1 for macaque, GRCm38 for mouse, Rnor_6.0 for 
rat). We included only the set of coding genes (*.cdna.all.fa files). We removed annotated 
secondary haplotypes of human genes by removing genes with ‘CHR_HSCHR’. 
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Quantifying differential gene expression in response to dsRNA. To quantify differential gene 
expression between treatment and control for each species and for each treatment separately, 
we used edgeR (version 3.12.1)55 using the rounded estimated counts from Salmon. This was 
done only for genes that had a significant level of expression in at least one of the four 
species (TPM >3 [Author: Please define TPM]in at least N – 1 libraries, where N is the 
number of different individuals we have for this species with libraries that passed quality 
control). Differential expression analysis was performed using the edgeR exact test, and P 
values were adjusted for multiple testing by estimating the false discovery rate (FDR). 
Conservation and divergence in response: fold-change-based phylogeny. We compared the 
overall change in response to treatment (dsRNA or IFNB) between pairs of species, by 
computing the Spearman correlation of the fold-change in response to treatment across all 
one-to-one orthologues that were expressed in at least one species (Extended Data Fig. 1a–h). 
Fold-change was calculated with edgeR, as described above. Spearman correlations of all 
expressed genes appear in grey. Correlations of the subset of differentially expressed genes 
(genes with FDR-corrected P < 0.01 in at least one of the compared species) appear in black. 
In Extended Data Fig. 1a–c, we show comparisons in response to dsRNA. In 
Extended Data Fig. 1d–f, we show comparisons in response to IFNB, which we use here to 
study the similarity of the secondary immune response between species. 
We constructed a tree based on a gene’s change in expression in response to dsRNA 
and to IFNB, using expressed genes that had one-to-one orthologues across all four species 
and were expressed in at least one species in at least one condition (Extended Data Fig. 1i). 
We used hierarchical clustering, with the hclust command from the stats R package, with the 
distance between samples computed as 1 – , where  is the pairwise Spearman correlation 
between each pair of species mentioned above (a greater similarity, reflected in a higher 
correlation, results in a smaller distance) and ‘average’ as the clustering method. 
The above-mentioned analyses focus on one-to-one orthologues between the 
compared species. In Supplementary Table 6, we quantify the similarity in response between 
species (based on Spearman correlations) when adding genes with one-to-many orthologues. 
Quantifying gene expression divergence in response to immune challenge. To quantify 
transcriptional divergence in immune response between species, we focus on genes that have 
annotated one-to-one orthologues across the studied species (human, macaque, mouse and 
rat). 9,753 of the expressed genes have annotated one-to-one orthologues in all four species, 
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out of which 955 genes are differentially expressed in human in response to dsRNA treatment 
(genes with an FDR-corrected P < 0.01). 
We define a measure of response divergence (based on a previous study56) by 
calculating the differences between the fold-change estimates across the orthologues: 
response divergence = log[1/4 × i,j(log[FC primatei] − log[FC rodentj])2]. This measure 
takes into account the structure of the phylogeny, and gives a relative measure of divergence 
in response across all genes with one-to-one orthologues. 
To consider differences between species, we focus on between-clade differences 
(primates versus rodents), rather than on within-clade differences. In this way, we map the 
most significant macro-evolutionary differences along the longest branches of our four-
species phylogeny. In addition, averaging within clades acts as a reduction of noise56. 
We compared this divergence measure to two other measures that use models (and 
incorporate both between- and within-clade divergence) and found a strong correlation 
between the divergence estimates across the three approaches (Supplementary Figs. 3, 4). 
In most of the subsequent analyses, we focus on the 955 dsRNA-responsive genes: 
genes that were differentially expressed in response to dsRNA (genes that have an FDR-
corrected P < 0.01 in human, and have annotated one-to-one orthologues in the other three 
species). For some of the analyses, we split these 955 genes based on quartiles, into genes 
with high, medium and low divergence (Fig. 1c). 
We also studied how imprecisions in the fold-change estimates affected the response 
divergence estimates and subsequent analyses (Supplementary Figs. 5, 6). 
Comparison of response divergence between different functional groups. To compare the 
divergence rates between sets of dsRNA-responsive genes that have different functions in the 
innate immune response, we split these 955 genes into the following functional groups (all 
groups are mutually exclusive, and any gene that belongs to two groups was excluded from 
the latter group; human gene annotations were used). 
We first grouped genes by annotated molecular functions: viral sensors (genes that 
belong to one of the GO categories: GO:0003725 (dsRNA binding), GO:0009597 (detection 
of virus), and GO:0038187 (pattern recognition receptor activity)); cytokines, chemokines 
and their receptors (GO:0005125 (cytokine activity), GO:0008009 (chemokine activity), 
GO:0004896 (cytokine receptor activity), and GO:0004950 (chemokine receptor activity)); 
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transcription factors (taken from the Animal Transcription Factor DataBase (version 2.0)57); 
chromatin modulators (GO:0016568 (chromatin modification), GO:0006338 (chromatin 
remodelling), GO:0003682 (chromatin binding), and GO:0042393 (histone binding)); kinases 
and phosphatases (GO:0004672 (protein kinase activity) and GO:0004721 (phosphoprotein 
phosphatase activity)); ligases and deubiquitinases (GO:0016579 (protein deubiquitination), 
GO:0004842 (ubiquitin-protein transferase activity) and GO:0016874 (ligase activity)); and 
other enzymes (mostly involved in metabolism rather than regulation: GO:0003824 (catalytic 
activity)). The divergence response values of these functional subsets were compared to the 
entire group of 955 dsRNA-responsive genes (Fig. 2d, e). 
Next, we grouped genes by biological processes that are known to be important in the 
innate immune response: antiviral defence (GO:0051607 (defence response to virus)); 
inflammation (GO:0006954 (inflammatory response)); apoptosis (GO:0006915 (apoptotic 
process)); and regulation (GO annotations related to regulation of innate immune response 
pathways include only few genes. We thus used as the group of genes related to regulation, 
the merged group of genes that are annotated as transcription factors, chromatin modulators, 
kinases and phosphates or ligases and deubiquitinases, since all these groups include many 
genes that are known to regulate the innate immune response.) 
Gene lists belonging to the mentioned GO annotations were downloaded using 
QuickGo58. The distribution of response divergence values for each of the functional groups 
was compared with the distribution of response divergence of the entire set of dsRNA-
responsive genes. Cytokines, chemokines and their receptors are merged in Figs. 2d, e, 3c. 
Analogous comparisons of functional groups in IFNB response (with 841 IFNB-responsive 
genes) are shown in Supplementary Fig. 1. See additional analyses in Supplementary 
Information. 
Conservation of active chromatin marks analysis: alignment and peak calling of ChIP–seq 
reads. ChIP–seq reads were trimmed using trim_galore (version 0.4.1) with ‘–paired–trim1–
nextera’ flags. The trimmed reads were aligned to the corresponding reference genome (hg38 
for human, rheMac2 for macaque, mm10 for mouse, rn6 for rat; all these genomes 
correspond to the transcriptomes used for RNA-seq mapping) from the UCSC Genome 
Browser59 using bowtie2 (version 2.2.3) with default settings60. In all four species, we 
removed the Y chromosome. In the case of human, we also removed all alternative haplotype 
chromosomes. Following alignment, low-confident mapped and improperly paired reads 
were removed by samtools61 with ‘-q 30 –f 2’ flags. 
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology article 
 DOI: 2017-08-11208C 
Page 27 of 40 
Enriched regions (peaks) were called using MACS2 (v 2.1.1)62 with a corrected P 
value cutoff of 0.01 with ‘-f BAMPE -q 0.01 -B–SPMR’ flags, using input DNA as control. 
The genome sizes (the argument for ‘-g’ flag) used were ‘hs’ for human, ‘mm’ for mouse, 
3.0 × 109 for macaque and 2.5 × 109 for rat. Peaks were considered reproducible when they 
were identified in at least two of the three biological replicates and overlapped by at least 
50% of their length (non-reproducible peaks were excluded from subsequent analyses). 
Reproducible peaks were then merged to create consensus peaks from overlapping regions of 
peaks from the three replicates by using mergeBed from the bedtools suite63. 
Gene assignment and conservation of active promoters and enhancers. We subsequently 
linked human peaks with the genes they might be regulating as follows: H3K4me3 consensus 
peak was considered the promoter region of a given gene if its centre was between 2 kb 
upstream and 500 bp downstream of the annotated TSS of the most abundantly expressed 
transcript of that gene. 
Similarly, H3K27ac was considered the enhancer region of a given gene if its centre 
was in a distance above 1 kb and below 1 Mb, and there was no overlap (of 1 bp or more) 
with any H3K4me3 peak. 
In each case where, based on the distance criteria, more than a single peak was linked 
to a gene (or more than a single gene was linked to a peak), we took only the closest peak–
gene pair (ensuring that each peak will have up to one gene and vice versa). 
To compare active promoters and enhancers between species, we excluded any 
human peak that could not be uniquely mapped to the respective region in the other species. 
This was done by looking for syntenic regions of human peaks in the other three species by 
using liftOver64, and removing peaks that had either unmapped regions or more than one 
mapped region in the compared species. We considered syntenic regions with at least 10% 
sequence similarity between the species (minMatch = 0.1), with a minimal length (minSizeQ 
and minSizeT) corresponding to the length of the shortest peak (128 bp in H3K4 and 142 bp 
in H3K27). 
We defined an active human promoter or enhancer as conserved if a peak was 
identified in the corresponding region of the other species (we repeated this analysis by 
comparing human with each of the other three species separately). We compared the 
occurrence of conserved promoters and enhancers in genes that are highly divergent in 
response to dsRNA with low-divergence genes, and used Fisher’s exact test to determine the 
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statistical significance of the observed differences between high- and low-divergence genes 
(Extended Data Fig. 2). 
Promoter sequence analysis. To calculate the total number of transcription factor binding 
motifs in a gene’s active promoter region, we downloaded the non-redundant JASPAR core 
motif matrix (pfm_vertebrates.txt) from the JASPAR 2016 server65 and searched for 
significant matches for these motifs using FIMO66 in human H3K4me3 peaks. The TFBM 
density of peaks was calculated by dividing the total number of motif matches in a peak by 
the peak’s length. TBFM density values in human H3K4me3 peaks linked with high- and 
low-divergence genes were compared (Fig. 2a). 
PhyloP7 values were used to assess promoter sequence conservation67. Sequence 
conservation quantification was performed by taking the estimated nucleotide substitution 
rate for each nucleotide along the promoter sequence (500 bp upstream of the TSS of the 
relevant human gene). When several annotated transcripts existed, the TSS of the most 
abundantly expressed transcript was used (based on bulk RNA data). The substitution rate 
values from all genes were aligned, based on their TSS position, and a mean for each of the 
500 positions was calculated separately for the group of genes with high, medium and low 
response divergence. The two-sample Kolmogorov–Smirnov test was used to compare the 
paired distribution of rates between the means of the high-divergence and low-divergence 
sets of genes. To plot the mean values of the three sets of divergent genes, the geom_smooth 
function from the ggplot2 R package was used with default parameters (with loess as the 
smoothing method) (Fig. 2b). 
Human CGI annotations were downloaded from the UCSC genome table browser 
(hg38), and CGI genes were defined as those with a CGI overlapping their core promoter 
(300 bp upstream of the TSS reference position, and 100 bp downstream of it, as suggested 
previously18). Genes were defined as having a TATA box if they had a significant match to 
the Jaspar TATA box matrix (MA0108.1) in the 100 bp upstream of their TSS by FIMO66 
with default settings (we used a 100 bp window owing to possible inaccuracies in TSS 
annotations). We note that only 28 out of 955 dsRNA-responsive genes had a matching 
TATA-box motif in this region. For both TATA and CGI analyses, the promoter sequences 
of the human orthologues were used. 
Cell-to-cell transcriptional variability analysis: read mapping and quality control of scRNA-
seq (full-length RNA). Gene expression was quantified in a manner similar to the 
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quantification for bulk transcriptomics libraries described above. Low-quality cells were 
filtered using quality control criteria (cells with at least 100,000 mapped reads, with at least 
2,000 expressed genes with TPM > 3, with ERCC < 10% and MT < 40%). [Author: Please 
define ERCC and MT] This quality control filtering resulted in 240 cells from a first 
biological replicate, including two technical replicates (with a time course of 0, 4, 8 h). In a 
second larger biological replicate (with a dsRNA stimulation time course of 0, 2, 4, 8 h), 728 
cells passed quality control. Results throughout the manuscript relate to the second cross-
species biological replicate in which a higher proportion of cells passed QC, and the lower-
quality first replicate data were not considered further. 
Cell–cell variability analysis. To quantify the biological cell–cell variability of genes, we 
applied the DM (Distance to Median) approach—an established method, which calculates the 
cell–cell variability in gene expression while accounting for confounding factors such as gene 
expression level30. This is done by first filtering out genes that are expressed at low levels: for 
Smart-seq2 data we included only genes that had an average expression of at least 10 size-
factor normalized reads (except for Extended Data Fig. 9a, in which we reduced the threshold 
to 5, to allow a larger number of genes to be included in the comparisons). This procedure 
was done to filter genes that displayed higher levels of technical variability between samples 
owing to low expression. Second, to account for gene expression level, the observed cell–cell 
variability of each gene was compared with its expected variability, based on its mean 
expression across all samples and in comparison with a group of genes with similar levels of 
mean expression. This DM value is also corrected by gene length (in the case of Smart-seq2 
data), yielding a value of variability that can be compared across genes regardless of their 
length and mean expression values68. As a second approach, we used BASiCS69,70 (see 
Supplementary Information). 
We note that the relationship observed in Fig. 3a between response divergence and 
cell–cell variability is not an artefact, stemming from differences in expression levels. (A) 
With respect to cell–cell variability, a gene’s expression level is controlled for by DM 
calculations, where expression level is regressed by using a running median (Supplementary 
Fig. 14). (B) Similarly, we can regress the expression level measured in bulk RNA-seq from 
the quantified response divergence by subtracting the running median of expression from the 
divergence estimates. When repeating the analysis comparing cell–cell variability versus 
regressed response divergence, the relationship between the two is maintained 
(Supplementary Fig. 15). 
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Cytokine co-expression analysis. For the chemokine CXCL10, we built a network (using 
CytoScape71) of genes that correlate with CXCL10 in dsRNA-stimulated human fibroblasts 
and in at least one more species, using genes with a Spearman correlation value above 0.3 
(see Fig. 3d and Supplementary Information). 
Analysis of different evolutionary modes: coding sequence evolution analysis. The ratio 
dN/dS (non-synonymous to synonymous codon substitutions) of human genes across the 
mammalian clade was obtained from a previous study that used orthologous genes from 29 
mammals72. Distributions of dN/dS values were computed for each of the three groups of 
genes with low, medium and high divergence in response to dsRNA, and are plotted in Fig. 
4a. 
Rate of gene gain and loss analysis. The significance at which a gene’s family has 
experienced a higher rate of gene gain and loss in the course of vertebrate evolution, in 
comparison with other gene families, was retrieved from ENSEMBL73. The statistics 
provided by ENSEMBL are calculated using the CAFE method74, which estimates the global 
birth and death rate of gene families and identifies gene families that have accelerated rates of 
gain and loss. Distributions of the P values from this statistic were computed for each of the 
three groups of genes with low, medium and high divergence in response to dsRNA and are 
plotted as the negative logarithm values in Fig. 4b. 
Gene age analysis. Gene age estimations were obtained from ProteinHistorian75. To ensure 
that the results were not biased by a particular method of ancestral protein family 
reconstruction or by specific gene family assignments, we used eleven different estimates for 
mammalian genes (combining five different databases of protein families with two different 
reconstruction algorithms for age estimation, as well as an estimate from the 
phylostratigraphic approach). For each gene, age was defined with respect to the species tree, 
where a gene’s age corresponds to the branch in which its family is estimated to have 
appeared (thus, larger numbers indicate evolutionarily older genes). 
Data for gene age in comparison with divergence in response to dsRNA are shown in 
Fig. 4c (using Panther7 phylogeny and Wagner reconstruction algorithm) and in 
Supplementary Fig. 17a (for all 11 combinations of gene family assignments and ancestral 
family reconstructions). See additional analyses in Supplementary Information. 
Cellular protein–protein interaction analysis. Data on the number of experimentally 
validated PPIs for human genes were obtained from STRING (version 10)76. Distributions of 
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PPIs for genes with low, medium and high divergence in response to dsRNA are plotted in 
Fig. 4d. 
Host–virus interaction analysis. Data on host–virus protein–protein interactions were 
downloaded from the VirusMentha database43, and combined with two additional studies that 
have annotated host–virus protein–protein interactions6,44. We split the 955 dsRNA-
responsive genes into genes with known viral interactions (genes whose protein products 
were reported to interact with at least one viral protein), and genes with no known viral 
interactions: ‘viral interactors’ and ‘no viral interactions’, respectively, in Fig. 4e. In addition, 
we define a subset of genes within the viral interactors set: those known to interact with viral 
proteins that are immunomodulators (proteins known to target the host immune system and 
modulate its response45). 
We note that the results presented in Fig. 4e are in agreement with previous analyses 
that are based on all human genes and on coding sequence evolution46. However, the overlap 
in the sets of genes between the previous analyses and the one presented here is small (for 
example, in one published study46 there were 535 human genes with known interactions with 
pathogens, 57 of which overlap with the 955 genes that are the basis of the current analysis). 
Additional experiments with human fibroblasts and human skin tissue 
Additional experiments were performed with human dermal fibroblasts and with cells 
extracted from human skin tissues to study in greater detail the relationship between response 
divergence across species and cell–cell variability. See Supplementary Methods and 
Supplementary Discussion for details. 
Cross-species bone marrow-derived phagocyte stimulation with LPS and dsRNA 
Tissue culture. Primary bone marrow-derived mononuclear phagocytes originating from 
females of four different species (black 6 mouse, brown Norway rat, rabbit and pig) were 
obtained from PeloBiotech. Twenty-four hours before the start of the stimulation time course, 
cells were thawed and split into 12-well plates (500,000 cells per well). Cells were stimulated 
with: (1) 100 ng/ml LPS (Invivogen, tlrl-smlps), or with (2) 1 g/ml high-molecular weight 
poly I:C (Invivogen, tlrl-pic) transfected with 2 l/ml Lipofectamin 2,000 (ThermoFisher, 
11668027). LPS stimulation time courses of 0, 2, 4, 6 h were performed for all species. Poly 
I:C stimulations were performed for rodents for 0, 2, 4, 6 h. We also processed cells for bulk 
RNA-seq for 0 and 4 h stimulation time points. Details on the individuals used in each 
technique are listed in Supplementary Table 2. 
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Library preparation for single cells using microfluidic droplet cell capture. Following 
stimulation, cells were collected using Cell Dissociation Solution Non-enzymatic (Sigma-
Aldrich, C5914), washed and resuspended in 1 × PBS with 0.5% (w/v) BSA. Cells were then 
counted and loaded on the 10× Chromium machine aiming for a targeted cell recovery of 
5,000 cells according to the manual. Libraries were prepared following the Chromium Single 
Cell 3 v2 Reagent Kit Manual77. Libraries were sequenced on Illumina HiSeq 4000 
instrument with 26 bp for read 1 and 98 bp for read 2. 
Library preparation and sequencing for bulk RNA-seq. Total RNA was extracted and 
libraries were prepared as described in the fibroblasts section. Pooled samples were 
sequenced on an Illumina HiSeq 4000 instrument, using paired-end 75-bp reads. 
Quantifying gene expression in bulk RNA transcriptomics. Adaptor sequences and low-
quality score bases were trimmed using Trim Galore (version 0.4.1). Trimmed reads were 
mapped and gene expression was quantified using Salmon: (version 0.9.1)54 with the 
following command: ‘salmon quant -i [index_file_directory] / -l ISR -p 8–seqBias–gcBias–
posBias -q -o [output_directory] -1 -g [ENSEMBL_transcript_to_gene_file]–useVBOpt–
numBootstraps 100’. Mouse samples were mapped to mouse transcriptome (ENSEMBL, 
version 84). We note that we used the bulk data only for TSS analysis. For differential 
expression analysis, we used an in silico bulk from the single-cell data (see below). 
Quantifying gene expression in microfluidic droplet cell capture data. Microfluidic droplet 
cell capture data was first quantified using 10× Genomics’ Cell Ranger Single-Cell Software 
Suite (version 2.0, 10× Genomics Inc.)77 against the relevant genome (ENSEMBL, version 
84). We removed cells with fewer than 200 genes or more than 10% mitochondrial reads. To 
remove potential doublets, we excluded the top 10% of cells expressing the highest numbers 
of genes. Genes expressed in less than 0.5% of the cells were excluded from the calculations. 
We then filtered cells that expressed fewer than 10% of the total number of filtered genes. 
Since bone marrow-derived phagocytes may include secondary cell populations, we 
focused our analysis on the major cell population. We identified clusters within each data set, 
using the Seurat78 functions RunPCA, followed by FindClusters (using 20 dimensions from 
the PCA, default perplexity and a resolution of 0.1) and have taken the cells belonging to the 
largest cluster for further analysis, resulting in a less heterogeneous population of cells. A 
lower resolution of 0.03 was used for rabbit-LPS4, rabbit-LPS2, mouse-PIC2, mouse-PIC4; 
and 0.01 for rabbit-LPS6. 
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Quantifying gene expression divergence in response to immune challenge. We created an in 
silico bulk table by summing up the UMIs of the post-QC single cells belonging to the largest 
cluster of cells, in each of the samples. We then used the three replicates in unstimulated 
conditions and in 4 h LPS stimulation to perform a differential expression analysis using 
DESeq279 Wald test, and P values were adjusted for multiple testing by estimating the FDR. 
A similar procedure was performed with mouse and rat dsRNA stimulation (with 4 h dsRNA 
stimulation versus unstimulated conditions). 
To quantify transcriptional divergence in immune response between species, we 
focused on genes that have annotated one-to-one orthologues across the studied species. 
We define a measure of response divergence by calculating the differences between 
the fold-change estimates across the orthologues: response divergence = log[1/3 × j(log[FC 
pig] − log[FC glirej])2]. For each gene, the fold-change in the outer group (pig), is subtracted 
from the fold-change in the orthologues of the three glires (mouse, rat and rabbit), and the 
average of the square values of these subtractions is taken as the response divergence 
measure. In most of the analyses, we focus on the 2,336 LPS-responsive genes—genes that 
are differentially expressed in response to LPS (genes that have an FDR-corrected P < 0.01 in 
mouse, and have annotated one-to-one orthologues in the other three species). 
Promoter elements, gene function and cell–cell variability analyses. Promoter elements 
(TATA and CGIs), gene function and cell–cell variability analyses were performed as 
described in the fibroblasts section. Mouse genes were used as the reference for gene function 
and TSS annotations. For variability analysis, we used one representative replicate out of 
three. 
Statistical analysis and reproducibility 
Statistical analyses were done with R version 3.3.2 for Fisher’s exact test, two-sample 
Kolmogorov–Smirnov test and Mann–Whitney test. Data in boxplots represent the median, 
first quartile and third quartile with lines extending to the furthest value within 1.5 of the 
inter-quartile range (as implemented by the R function geom_boxplot). Violin plots show the 
kernel probability density of the data (as implemented by the R function geom_violin). 
All cross-species bulk RNA-Seq replicates were successful, except for one macaque 
individual in which the treated sample had a low RNA quality and was removed from the 
analysis (along with the matching control). All cross-species ChIP–seq replicates were 
successful. Cross-species scRNA-seq of fibroblasts was performed in two biological 
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replicates. Results throughout the manuscript relate to the second cross-species biological 
replicate, for which a higher proportion of cells passed technical quality control. Three out of 
three replicates for each species and condition were successful when preparing single-cell 
libraries for mononuclear phagocytes, except for two libraries that failed at the emulsion 
preparation stage. Two out of two replicates of single-cell in situ RNA hybridization assay 
were performed and both are shown. 
Reporting summary 
Further information on experimental design is available in the Nature Research Reporting 
Summary linked to this paper. 
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Scripts for major analyses are available at https://github.com/Teichlab/innate_evo. 
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Extended Data Fig. 1 | Fibroblast response to dsRNA and IFNB across species. To study 
the similarity in response to treatment across species, we plotted the fold-change values of all 
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expressed genes (with one-to-one orthologues) between pairs of species (human–macaque, 
mouse–rat and human–mouse) in response to dsRNA (poly I:C) (a–c). As a control, we 
performed the same procedure with IFNB stimulations (d–f). Fold-changes were inferred 
from differential expression analyses, determined by the exact test in the edgeR package6 and 
based on n = 6, 5, 3 and 3 individuals from human, macaque, rat and mouse, respectively. 
Spearman correlations between all expressed one-to-one orthologues are shown in grey, 
Spearman correlations between the subset of differentially expressed genes (FDR-corrected 
P < 0.01 in at least one species) appear in black. Number of genes shown is n = 11,035, 
11,005, 11,137, 10,851, 10,826 and 10,957 in a–f, respectively. Genes are coloured blue if 
they were differentially expressed (FDR-corrected P < 0.01) in both species, purple if they 
were differentially expressed in only one species, or red if they were not differentially 
expressed. g, h, Density plots of ratio of fold-change in response to dsRNA or to IFNB. g, 
Comparison between human and macaque orthologues in dsRNA response. h, Comparison 
between human and mouse orthologues in IFNB response. i, Dendrogram based on the fold-
change in response to dsRNA or to IFNB across 9,835 one-to-one orthologues in human, 
macaque, rat and mouse. 
Extended Data Fig. 2 | Correspondence of transcriptional divergence and divergence of 
active promoters and enhancers. Comparison of divergence in transcriptional response to 
dsRNA with divergence of active chromatin marks in active promoters (a, profiled using 
H3K4me3 in proximity to gene’s TSS) and enhancers (b, H3K27ac without overlapping 
H3K4me3). Chromatin marks were linked to genes on the basis of their proximity to the 
gene’s TSS. Chromatin marks were obtained from n = 3 individuals in each of the four 
species, from fibroblasts stimulated with dsRNA or left untreated. The statistics are based on 
n = 855, 818 and 813 human genes that have a linked H3K4me3 mark with a syntenic region 
in macaque, rat and mouse, respectively (a); and on n = 326, 241 and 242 human genes that 
have a linked H3K27ac mark with a syntenic region in macaque, rat and mouse, respectively 
(b). Each panel shows the fraction of conserved marks between human and macaque, rat or 
mouse, in genes that have high, medium and low divergence in their transcriptional response. 
In each column, the histone mark’s signal was compared between human and the syntenic 
region in one of the three other species. If an active mark was found in the corresponding 
syntenic region, the linked gene was considered to have a conserved active mark (promoter or 
enhancer). The fractions of genes with conserved promoters (or enhancers) in each pair of 
species were compared between high- and low-divergence genes using a one-sided Fisher’s 
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exact test. When comparing active promoter regions of high- versus low-divergence genes, 
we observe that low-divergence genes have a significantly higher fraction of conserved 
marks in rodents. This suggests an agreement between divergence at the transcriptional and 
chromatin levels in active promoter regions. In active enhancer regions, we do not observe 
these patterns, suggesting that the major contribution to divergence comes from promoters. 
Extended Data Fig. 3 | Comparison of response divergence of genes containing various 
promoter elements. Comparison of response divergence between genes with and without a 
TATA-box and CGI. Left, fibroblasts (n = 14, 14, 633 and 294 differentially expressed genes 
with only TATA-box element, with both CGI and TATA-box elements, with only CGI, and 
with neither element in their promoters, respectively); right, phagocytes (n = 13, 29, 1,718 
and 576 differentially expressed genes with only a TATA-box element, with both CGI and 
TATA-box elements, with only a CGI, and with neither element in their promoters, 
respectively). Genes with a TATA-box without a CGI have higher response divergence than 
genes with both elements. Genes with a CGI but without a TATA-box diverge more slowly 
than genes with both elements. Genes with both elements do not differ significantly in their 
divergence from genes lacking both elements (one-sided Mann–Whitney test). Data in 
boxplots represent the median, first quartile and third quartile with lines extending to the 
furthest value within 1.5 of the IQR. 
Extended Data Fig. 4 | Response divergence of molecular processes upregulated in 
immune response. Left, distributions of divergence values of n = 955 dsRNA-responsive 
genes in fibroblasts and subsets of this group belonging to different biological processes. For 
each functional subset, the distribution of divergence values is compared with the set of 955 
dsRNA-responsive genes using a one-sided Mann–Whitney test. FDR-corrected P values are 
shown above each group and group size is shown inside each box. Right, distributions of 
divergence values of n = 2,336 LPS-responsive genes in mononuclear phagocytes and subsets 
of this group belonging to different biological processes. For each functional subset, the 
distribution of divergence values is compared with the set of 2,336 LPS-responsive genes. 
FDR-corrected P values (one-sided Mann–Whitney test) are shown above each group and 
group size is shown inside each box. Data in boxplots represent the median, first quartile and 
third quartile with lines extending to the furthest value within 1.5 of the IQR. [Author: ED 
Figure is not labelled a and b so I have changed the legend to left and right, ok?] 
Extended Data Fig. 5 | Cell–cell variability versus response divergence across species 
and conditions in fibroblasts after dsRNA stimulation. Cell–cell variability values, as 
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measured with DM across individual cells, compared with response divergence between 
species (grouped into low, medium and high divergence). Variability values are based on 
n = 29, 56, 55, 35 human cells, n = 20, 32, 29, 13 rhesus cells, n = 33, 70, 65, 40 rat cells, and 
n = 53, 81, 59, 30 mouse cells, stimulated with dsRNA for 0, 2, 4 and 8 h, respectively. Rows 
represent different dsRNA stimulation time points (0, 2, 4 and 8 h), and columns represent 
different species as shown. High-divergence genes were compared with low-divergence 
genes using a one-sided Mann–Whitney test. Data in boxplots represent the median, first 
quartile and third quartile with lines extending to the furthest value within 1.5 of the IQR. 
Extended Data Fig. 6 | Cell–cell variability versus response divergence across species 
and conditions in mononuclear phagocytes after LPS stimulation. Cell–cell variability 
values, as measured with DM across cells, compared with response divergence between 
species (grouped into low, medium and high divergence). Variability values are based on 
n = 3,519, 4,321, 3,293, 2,126 mouse cells, n = 2,266, 2,839, 1,963, 1,607 rat cells, n = 3,275, 
1,820, 1,522, 1,660 rabbit cells, and n = 1,748, 1,614, 1,899, 1,381 pig cells, stimulated with 
LPS for 0, 2, 4 and 6 h, respectively. Rows represent different LPS stimulation time points (0, 
2, 4 and 6 h), and columns represent different species as shown. High-divergence genes were 
compared with low-divergence genes using a one-sided Mann–Whitney test. Data in boxplots 
represent the median, first quartile and third quartile with lines extending to the furthest value 
within 1.5 of the IQR. 
Extended Data Fig. 7 | Cell–cell variability of cytokine expression in single cell in situ 
RNA hybridization assay combined with flow cytometry (PrimeFlow). PrimeFlow 
measurement of two cytokine genes (IFNB and CXCL10) that show high cell–cell variability 
in scRNA-seq. As controls, two genes matched on expression levels (ATXN2L and ADAM32) 
but that show low cell–cell variability in scRNA-seq data are shown. As the expression of 
cytokines is at the low end of the distribution, we also chose two genes with middle-range 
expression values (ADAMTSL3 and BRD2) as additional controls. The experiment was 
performed in n = 2 independent replicates, originating from the same individual. Both 
replicates are shown. a, Pseudocolour contour plot for RNA target expression in dsRNA-
stimulated human fibroblasts. The x-axis shows area of side scatter (SSC-A) and the y-axis 
shows fluorescent signal for target RNA probes. RNA targets detected by the same 
fluorescent channel are displayed together. Top, IFNB and control genes BRD2 and ATXN2L, 
type 1 probe, Alexa FluorTM 647. Bottom, CXCL10 and control genes ADAMTSL3 and 
ADAM32, type 10 probe, Alexa FluorTM 568. The cytokine genes display a broader range of 
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fluorescence signal than the controls. b, Histograms comparing fluorescence of cytokine and 
control pairs (IFNB–BRD2 for type 1 probe and CXCL10–ADAM32 for type 10 probe). The 
histograms show a bimodal distribution of expression signal for the two cytokine genes 
(IFNB and CXCL10, red), but not for controls (blue). This agrees with scRNA-seq data in 
which CXCL10 and IFNB display high levels of cell-to-cell variability. 
Extended Data Fig. 8 | Cell–cell variability levels and response divergence of cytokines, 
transcription factors and kinases in response to LPS stimulation of phagocytes. A scatter 
plot showing divergence in response to LPS across species and transcriptional cell–cell 
variability in mouse mononuclear phagocytes following 4 h of LPS treatment, in n = 2,262 
LPS-responsive genes. Purple, cytokines; green, transcription factors; beige, kinases. The 
distributions of divergence values and cell–cell variability values of each of the three 
functional groups are shown above and to the right of the scatter plot, respectively. 
Extended Data Fig. 9 | Cell–cell variability levels in cytokines, transcription factors and 
kinases across species and stimulation time points. Violin plots showing the distribution of 
cell–cell variability values (DM) of cytokines, transcription factors and kinases during 
immune stimulation. Left, fibroblast dsRNA stimulation time course. Number of cells used in 
each species (at 2, 4, 8 h dsRNA, respectively): human, 56, 55, 35; macaque, 32, 29, 13; rat, 
70, 65, 40; mouse, 81, 59, 30. Right, phagocyte LPS stimulation time course. Number of cells 
used in each species (at 2, 4, 6 h LPS, respectively): mouse, 4,321, 3,293, 2,126; rat, 2,839, 
1,963, 1,607; rabbit, 1,820, 1,522, 1,660; pig, 1,614, 1,899, 1,381. For both panels, colours as 
in Fig. 3c. Comparisons between groups of genes were performed using one-sided Mann–
Whitney tests. Violin plots show the kernel probability density of the data. 
Extended Data Fig. 10 | Percentage of cells expressing cytokines, transcription factors 
and kinases. Histograms showing the percentage of fibroblasts expressing cytokines (top), 
transcription factors (middle) and kinases (bottom) following 4 h dsRNA stimulation, in 
human, macaque, rat and mouse cells (based on n = 55, 29, 65 and 59 cells, respectively). 
The percentage of expressing cells is divided into 13 bins (x-axis). The y-axis represents the 
fraction of genes from this gene class (for example, cytokines) that are expressed in each bin 
(for example, in human, nearly 30% of the cytokine genes (y-axis) are expressed in the first 
bin, corresponding to expression in fewer than 8% of cells). 
